Pharmaceutical News

RSS

Pharmacy teams still not receiving adequate COVID-19 risk assessments, survey finds

A new survey carried out by the Royal Pharmaceutical Society and the UK Black Pharmacists Association has found that pharmacy teams are still not receiving adequate individual COVID-19 risk assessments.

13 Aug 2020

New treatment regimens show early efficacy for multidrug-resistant tuberculosis

New treatment regimens for multidrug-resistant tuberculosis (MDR-TB) have shown early effectiveness in 85 percent of patients in a cohort that included many people with serious comorbidities that would have excluded them from clinical trials, according to the results of a new international study.

13 Aug 2020

Bayer supports WHO through donated medicines for treatment of T. solium infection

A recent agreement between the World Health Organization and the German pharmaceutical company Bayer promises hope of expanding access to essential medicines for the treatment of people exposed to or infected by the pork tapeworm Taenia solium.

12 Aug 2020

FDA approves new treatment option for patients with rare Duchenne muscular dystrophy mutation

Today, the U.S. Food and Drug Administration granted accelerated approval to Viltepso (viltolarsen) injection for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.

12 Aug 2020

Study: Anti-microRNA drug significantly reduces miR-92a levels in human peripheral blood

A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans.

12 Aug 2020

Using medieval medicine to find new treatments for modern-day infections

News-Medical spoke to researchers from the University of Warwick about their research investigating natural antimicrobials and their potential as antibiotics.

11 Aug 2020

Opioid risk is higher for patients transitioning to skilled nursing facilities

Hospital patients discharged to skilled nursing facilities often bring a high-dose painkiller prescription with them, suggesting more attention should be paid to opioid safety for those patients, research from the Oregon State University College of Pharmacy shows.

11 Aug 2020

Finland joins international organization dedicated to COVID-19 vaccines

The flag of Finland was raised at the International Vaccine Institute (IVI) Headquarters today during a ceremony welcoming the country's accession to IVI.

11 Aug 2020

First-time opioid prescriptions may lead to substance-related problems later in life

Young adults and adolescents who are prescribed opioids for the first time may be at a slightly greater risk of developing a substance-related problem later in life, according to a new study co-authored by Indiana University researchers.

11 Aug 2020

Specific HIV and tuberculosis medications decrease risk of death in adults with drug-resistant TB

After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.

11 Aug 2020

Vaccine 'nationalism' will slow coronavirus fight if poor countries are left exposed

As the coronavirus vaccine race charges on, many of the investigational candidate vaccines are nearing the final stages of human trials. The results of these trials will determine if they will be granted the green light to manufacture and distribute the vaccine to countries across the globe.

10 Aug 2020

FDA approves opioid agonist for management of moderate to severe acute pain in adults

Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.

9 Aug 2020

FDA approves first oral drug for treatment of spinal muscular atrophy

The U.S. Food and Drug Administration today approved Evrysdi (risdiplam) to treat patients two months of age and older with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.

7 Aug 2020

New test can pinpoint which people with gonorrhea can be cured with ciprofloxacin

A test designed by UCLA researchers can pinpoint which people with gonorrhea will respond successfully to the inexpensive oral antibiotic ciprofloxacin, which had previously been sidelined over concerns the bacterium that causes the infection was becoming resistant to it.

7 Aug 2020

Study: Inhaled sedatives can reduce lung inflammation, improve survival

A team from Lawson Health Research Institute are being funded by the Government of Ontario's COVID-19 Rapid Research Fund to study whether inhaled sedatives can replace those that are delivered intravenously in COVID-19 patients requiring ventilation.

6 Aug 2020

New protocol reduces opioid use following surgery

The majority of patients who followed an "Enhanced Recovery After Surgery" (ERAS) protocol did not need opioids for pain management at multiple time points following elective spinal and peripheral nerve surgery.

6 Aug 2020

RPS calls for community pharmacists to be allowed to alter prescriptions

The Royal Pharmaceutical Society is calling for all community pharmacists to be allowed to make changes to prescriptions that would reduce unnecessary delays in providing medicines to patients if the item prescribed was in short supply or out of stock.

6 Aug 2020

Study: UnityPhilly app can help fight America's opioid crisis

Equipped with naloxone and a smartphone app, community members can save lives in the fight against America's opioid crisis, according to a paper from researchers at Drexel University's Dornsife School of Public Health and colleagues published this week in The Lancet journal EClinicalMedicine.

6 Aug 2020

Medicare Part D insurance plans largely favor generics over brand-name drugs

Contrary to previous media reports, a new study led by Vanderbilt University Medical Center researchers finds that Medicare Part D prescription drug insurance plans largely favor generic drugs over brand-name counterparts.

5 Aug 2020

European Commission approves first drug for hepatitis D

What started off as basic research 25 years ago has now lead to a successfully approved drug: The entry blocker bulevirtide (brand name Hepcludex, formerly known as Myrcludex B), jointly developed by researchers from Heidelberg University Hospital (UKHD) and the Medical Faculty of Heidelberg, the DZIF and other partners, has now been approved by the European Commission.

5 Aug 2020

Pharmaceutical News

Pharmacy teams still not receiving adequate COVID-19 risk assessments, survey finds

New treatment regimens show early efficacy for multidrug-resistant tuberculosis

Bayer supports WHO through donated medicines for treatment of T. solium infection

FDA approves new treatment option for patients with rare Duchenne muscular dystrophy mutation

Study: Anti-microRNA drug significantly reduces miR-92a levels in human peripheral blood

Using medieval medicine to find new treatments for modern-day infections

Opioid risk is higher for patients transitioning to skilled nursing facilities

Finland joins international organization dedicated to COVID-19 vaccines

First-time opioid prescriptions may lead to substance-related problems later in life

Specific HIV and tuberculosis medications decrease risk of death in adults with drug-resistant TB

Vaccine 'nationalism' will slow coronavirus fight if poor countries are left exposed

FDA approves opioid agonist for management of moderate to severe acute pain in adults

FDA approves first oral drug for treatment of spinal muscular atrophy

New test can pinpoint which people with gonorrhea can be cured with ciprofloxacin

Study: Inhaled sedatives can reduce lung inflammation, improve survival

New protocol reduces opioid use following surgery

RPS calls for community pharmacists to be allowed to alter prescriptions

Study: UnityPhilly app can help fight America's opioid crisis

Medicare Part D insurance plans largely favor generics over brand-name drugs

European Commission approves first drug for hepatitis D

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News